Andere Sprachen Glycorex Transplantation AB

Aktien

GTAB B

SE0000524530

GTAB B

Schlusskurs NORDIC GROWTH MARKET Andere Börsenplätze 00:00:00 24.06.2024			% 5 Tage	% 1. Jan.
1,005 ^SEK	-2,90 %		-1,47 %	-24,15 %

23.05.	Glycorex Transplantation AB (publ) meldet Ergebniszahlen für das erste Quartal zum 31. März 2024	CI
28.02.	Glycorex Transplantation AB (publ) berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Glycorex Transplantation AB Reports Earnings Results for the First Quarter Ended March 31, 2024	23.05.
Glycosorb® ABO is pushing the boundaries in paediatric blood group incompatible heart transplantation	13.05.
First publication from South Africa and first stem cell transplantation performed in Mexico	08.05.
Glycorex Transplantation AB Reports Earnings Results for the Full Year Ended December 31, 2023	28.02.
Glycorex Transplantation AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28.02.
Glycorex Transplantation (GTAB B): Signs agreement with distributor in Romania	20.02.
Glycorex Transplantation AB: Entering into an agreement with Bio-Rad Laboratories, Inc.	29.11.
Glycorex Transplantation AB (publ): Interim Report January - September 2023	29.11.
Glycorex Transplantation AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	29.11.
Glycorex Transplantation AB (publ): Interim Report January - June 2023	30.08.23
Glycorex Transplantation AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	30.08.23
Glycorex Transplantation AB (publ): Interim Report January - March 2023	24.05.23
Glycorex Transplantation AB Reports Earnings Results for the First Quarter Ended March 31, 2023	24.05.23
Annual Report 2022 Glycorex Transplantation AB (publ)	28.04.23
Published study from the US shows promising results on the use of Glycosorb® ABO to provide low-titer group O whole blood	09.03.23
Glycorex Transplantation AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	28.02.23
The first blood group incompatible kidney transplant using Glycosorb® ABO performed in South Africa	20.02.23
Glycorex strengthens the organization to place additional force behind the growth strategy Going 4 Growth	31.01.23
Glycorex Transplantation AB (GTAB B): Interim report January - September 2022	24.11.22
Glycorex Transplantation AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	24.11.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Glycorex Transplantation AB

Aktien

GTAB B

SE0000524530

GTAB B

Andere Sprachen

Filter